Just a reminder that the registration cost goes up after June 30th for our Acquired Resistance to EGFR or ALK/ROS inhibitors patient forum in Boston on September 9, 2014. Check below to learn the details of this day-long program that will feature a diverse, star-studded faculty of the leaders in this important field, including our own "CraiginPA", Bonnie Addario, FDA representative Dr. Gideon Blumenthal on drug development for narrow populations, and of course many of the leaders in developing the novel agents we're excited about!
We're sure to have a high energy day, with about 60 people already signed up. I expect there to be at least 100-200 people, all very motivated to learn and talkl about best management practices now and emerging options. And we'll be at a lovely Boston hotel across the street from the Boston Commons and steps from many of the city's most remarkable attractions.
Sign up before the very modest registration cost goes up. I hope we'll see you there!